Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
作者信息
Daniel Olusoji J, Krain Alysa B, Ogun Shamsideen A, Odusoga Okanlawon L, Boyle Brian A
机构信息
Centre for Special Studies Nigeria, Olabissi Onabanjo University Teaching Hospital, Sagamu, Ogun State, Nigeria.
出版信息
J Natl Med Assoc. 2005 Dec;97(12):1719-21.
Abstract
Nevirapine associated rash has been well described in the Caucasian population. With increasing access to antiretroviral treatment--especially a fixed dose combination--by people living with HIV/AIDS in developing countries, there is a need to emphasize the lead in doses of nevirapine. We strongly recommend a warning label on the bottle advising patients on the lead-in period and the signs and symptoms of significant rash.
摘要
相似文献
1
Nevirapine-related adverse events in a patient receiving a fixed-drug combination pill.
J Natl Med Assoc. 2005 Dec;97(12):1719-21.
2
DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
Clin Infect Dis. 1998 Nov;27(5):1321-2.
3
Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Pediatr Infect Dis J. 2007 Nov;26(11):1053-6. doi: 10.1097/INF.0b013e318125655d.
4
Is there cross-toxicity between nevirapine and efavirenz in subjects developing rash?
AIDS. 2000 Jul 28;14(11):1672-3. doi: 10.1097/00002030-200007280-00032.
5
Female sex and the use of anti-allergic agents increase the risk of developing cutaneous rash associated with nevirapine therapy.
AIDS. 2001 Aug 17;15(12):1579-81. doi: 10.1097/00002030-200108170-00018.
6
Incidence and risk factors of rash associated with efavirenz in HIV-infected patients with preceding nevirapine-associated rash.
HIV Med. 2006 Sep;7(6):378-82. doi: 10.1111/j.1468-1293.2006.00396.x.
7
Nevirapine-associated rash in a Jamaican child with HIV/AIDS.
West Indian Med J. 2004 Oct;53(5):356-8.
8
Desensitization to Nevirapine.
TreatmentUpdate. 1999 Nov 1;11(8):5.
9
Sex differences in nevirapine rash.
Clin Infect Dis. 2001 Jan;32(1):124-9. doi: 10.1086/317536. Epub 2000 Dec 13.
10
[Exanthema simulating measles without measles virus? Allergic reaction to a non-nucleoside reverse transcriptase inhibitor in an HIV infected boy treated with HAART].
Hautarzt. 2003 Aug;54(8):765-6. doi: 10.1007/s00105-003-0567-5. Epub 2003 Jun 25.
本文引用的文献
1
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.
AIDS. 2003 Oct 17;17(15):2191-9. doi: 10.1097/00002030-200310170-00007.
2
Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
AIDS. 2001 Sep 28;15(14):1843-8. doi: 10.1097/00002030-200109280-00014.
3
Prevention of nevirapine-associated exanthema using slow dose escalation and/or corticosteroids.
AIDS. 2000 Sep 29;14(14):2153-7. doi: 10.1097/00002030-200009290-00012.
Zotero 插件